On August 23, 2024, Robert F. Kennedy Jr. made an appearance in Phoenix.
Photographed by Thomas Machowicz | Reuters
The nomination of Robert F. Kennedy Jr., a well-known vaccine skeptic, to head the Department of Health and Human Services by President-elect Donald Trump caused a drop in the stock prices of vaccine manufacturers on Thursday.
In the final hour of trading, reports about Trump’s anticipated selection led to a decline in stock prices. Moderna saw its stock decrease by over 5% on Thursday, Novavax shares fell by more than 7%, and Pfizer’s stock closed more than 2% lower.
BioNTech, the German pharmaceutical company that collaborated with Pfizer on a Covid vaccine, experienced a drop of over 6% in its share price. British drugmaker GSK, known for producing flu shots and various vaccines, closed around 2% lower.
Following Trump’s confirmation of his choice on his Truth Social platform, the stocks of these companies continued to decline during extended trading hours.
Experts in health policy have expressed concerns that if given a second term, Trump could empower Kennedy to promote anti-vaccine sentiments further which may discourage more Americans from getting vaccinated against Covid…
2024-11-14 17:05:08
Source from www.cnbc.com